| Asset | 31 Jul 2026 | 30 Jun 2026 | 31 May 2026 | 30 Apr 2026 | 31 Mar 2026 | 28 Feb 2026 |
|---|---|---|---|---|---|---|
| Equity | 100.03% | 100.06% | 100.09% | 100.08% | 99.86% | 101.41% |
| Debt | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Others (incl. cash) | -0.03% | -0.06% | -0.09% | -0.08% | 0.15% | -1.41% |
| Commodities | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Real Estate | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Instrument | Sector | No. of Shares | Value (Rs. Cr) | Weight | Change |
|---|---|---|---|---|---|
| Laurus Labs Ltd. | Healthcare | 1,23,006 | 22.34 | 10.79% | 1.43%↑ |
| Lupin Ltd. | Healthcare | 76,777 | 18.54 | 8.96% | -0.34%↓ |
| Fortis Healthcare Ltd. | Healthcare | 1,64,751 | 15.57 | 7.52% | -0.38%↓ |
| Aurobindo Pharma Ltd. | Healthcare | 87,509 | 13.83 | 6.68% | -0.31%↓ |
| Glenmark Pharmaceuticals Ltd. | Healthcare | 47,602 | 10.63 | 5.14% | -0.12%↓ |
| Alkem Laboratories Ltd. | Healthcare | 18,499 | 10.64 | 5.14% | -0.03%↓ |
| Biocon Ltd. | Healthcare | 2,25,557 | 9.6 | 4.64% | -0.09%↓ |
| Mankind Pharma Ltd. | Healthcare | 35,792 | 8.84 | 4.27% | -0.29%↓ |
| Ipca Laboratories Ltd. | Healthcare | 43,915 | 7.68 | 3.71% | -0.03%↓ |
| Krishna Institute of Medical Sciences Ltd | Healthcare | 81,958 | 6.6 | 3.19% | 0.00% |
| Aster DM Quality Care Ltd. | Healthcare | 80,045 | 6.58 | 3.18% | 0.03%↑ |
| Gland Pharma Ltd. | Healthcare | 25,191 | 6.31 | 3.05% | -0.10%↓ |
| Sai Life Sciences Ltd. | Healthcare | 43,620 | 5.74 | 2.77% | 0.08%↑ |
| Neuland Laboratories Ltd. | Healthcare | 2,726 | 5.19 | 2.51% | -0.03%↓ |
| Wockhardt Ltd. | Healthcare | 26,108 | 5.12 | 2.47% | -0.07%↓ |
| Acutaas Chemicals Ltd. | Healthcare | 16,395 | 5.09 | 2.46% | - |
| Dr. Lal Pathlabs Ltd. | Healthcare | 24,638 | 4.69 | 2.27% | 0.24%↑ |
| Ajanta Pharma Ltd. | Healthcare | 13,315 | 4.61 | 2.23% | -0.05%↓ |
| Abbott India Ltd. | Healthcare | 1,647 | 4.58 | 2.21% | 0.11%↑ |
| Narayana Hrudayalaya Ltd. | Healthcare | 21,844 | 4.43 | 2.14% | -0.02%↓ |
| Sector | 31 Jul 2026 | 30 Jun 2026 | 31 May 2026 | 30 Apr 2026 | 31 Mar 2026 | 28 Feb 2026 |
|---|---|---|---|---|---|---|
| Healthcare | 100.03% | 100.06% | 100.09% | 100.08% | 99.86% | 101.41% |
28.3 / 100
Weighted average Value score is 28.3. This indicates that portfolio is relatively reasonably valued using composite of value measures.
69.1 / 100
Weighted average Price Momentum score is 69.1. This indicates that portfolio has average momentum using composite of momentum measures.
79.2 / 100
Weighted average Quality score is 79.2. This indicates that portfolio has high quality using composite of quality measures.
66.2 / 100
Weighted average QVM score is 66.2. This indicates that portfolio has average QVM score and hence a neutral stance is warranted.
